Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDVRG.L Regulatory News (DVRG)

  • There is currently no data for DVRG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

DeepVerge to explore options for Labskin Division

20 Jul 2022 07:00

RNS Number : 0289T
Deepverge PLC
20 July 2022
 

 

20 July 2022

 

DeepVerge PLC

 

("DeepVerge" or "the Company" or "the Group")

 

DeepVerge to explore options for Labskin Division in response to the success of Skin Trust Club

7,000 new Skin Trust Club members joined last month

 

DeepVerge plc (AIM: DVRG), announces a significant reorganisation of the Group. As from 7 June 2022 the Health / Life Science (Labskin) and Environmental Divisions have been separated and now run independently of each other. The Board notes recent interest and increased discussions with Tier 1 skincare corporations, US drugstores and venture capital backed companies, some of whom are clients, and is exploring a range of options to meet the unprecedented demand for Labskin services and the accelerating growth of Skin Trust Club.

 

Gerard Brandon CEO DeepVerge plc, commented:

"Due to the pace of growth of the consumer facing Skin Trust Club business, which can be compared to a Silicon Valley SaaS type service, demand is far outstripping supply for the home skin-test kits and the growing list of Labskin services from skin care manufacturers seeking to join Skin Trust Club marketplace. The Board believe it is necessary to explore options to maintain this level of growth within an expanded Group structure.. It is clear that Modern Water, the Environmental Division, is experiencing its own fast paced growth as highlighted in recent announcements."

 

The Health/Life Sciences Division comprises Labskin Services and Skin Trust Club.

KPI's of Skin Trust Club since January 2022

38,000 kits tested

27,000 Club Members (an increase of 7,000 between May and June)

42.5% of Club Members with skin conditions

24 new skin care clients joined the marketplace since January

300+ products added to Skin Trust Club marketplace since January

200+ products to be added shortly

82% of Club Members purchase recommended skin products generating fee income

84,000+ visits to website per month and growing (up more than 30,000 in one month)

80% traffic through mobile

1,700 data points per Club Member

80% female users aged 25 - 65

 

Background:

Skin Trust Club, powered by Labskin, has already outgrown the previously enlarged 9,387 square foot laboratories in York, UK and a further 924 square feet is currently being equipped to address the immediate demand in the UK for Skin Trust Club testing. Upgrading of the laboratories in Delaware, US, will provide an additional 5,000 square feet and is near completion. The US expanded laboratories are expected to accommodate the short term demand from Labskin clients and Skin Trust Club members on the East Coast of the US in Q3. The Irish laboratories in Fermoy, Cork, Ireland are also being equipped to address the EU market as new Labskin skincare clients and Skin Trust Club members grow.

 

Multiple streams of Skin Trust Club and Labskin revenues

As well as fee income from sales of skin care products recommended through Skin Trust Club App, the skin microbiome data continues to grow, increasing by thousands of new samples each month. This creates a rich learning environment for the Company's machine learning and AI. The world's largest skin microbiome database enables the Company to offer digital test solutions on a range of skin diseases to existing corporate clients and to the industry in general, for faster, better and more cost effective product development, offering the potential for future revenues for the platform.

 

 

 

DeepVerge plc

Gerard Brandon, CEO

 

+44 (0) 7340 055 648

SPARK Advisory Partners Limited

(Nominated Adviser)

 

Neil Baldwin/Andrew Emmott

+44 (0) 113 370 8974

Turner Pope Investments (TPI) Limited (Broker)

Andy Thacker/James Pope

+44 (0) 20 3657 0050

 

 

Market Abuse Regulation (MAR) Disclosure

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF ENGLISH LAW BY VIRTUE OF THE EUROPEAN (WITHDRAWAL) ACT 2018, AS AMENDED. ON PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INFORMATION IS CONSIDERED TO BE IN THE PUBLIC DOMAIN.

 

About DeepVerge plc (www.deepverge.com)

DeepVerge is an environmental and life science group of companies that develops and applies AI and IoT technology to analytical instruments for the analysis and identification of bacteria, virus and toxins; Utilising artificial intelligent data analytics to scientifically prove the impact of skincare product claims on skin.

 

DeepVerge comprises the following divisions:

 

Health / Life Sciences Division which contains the following activities:

 

Skin Trust Club

Skin Trust Club incorporates an artificial intelligence Skincare App and Home Test Kit that provide simple, at-home skin microbiome testing for personalised skincare and skin health tracking. The self-administered skin swab is a remote trial and allows the participant to conduct each stage of the trial without interaction. Skin Trust Club's DNA Test generates a report that consumers can use to manage their custom skincare regime. Analysis of skin attributes provides information to create hundreds of different product combinations to suit a person's unique skin microbiome.

 

Labskin

Labskin is a 3D human skin equivalent test platform that scientifically proves the impact of skincare product claims in healthcare, life sciences, skin microbiome clinical trials, pharmaceutical and cosmetics industries. Labskin have been pioneering the development of a laboratory grown human skin platform for 15 years and is the only commercially available lab-grown full thickness human skin model that naturally mimic the skins' microbiome. Labskin's virtual clinical trials with remote collection of human volunteers' skin microbiome provides a solution for the collection of volunteer microbiomes to allow for lab-controlled trials of advanced skin models and human microbiomes. As the data bank of remote volunteers grow, the higher the accuracy and increased reliability of virtual product testing that can be provided to clients, eliminating early human trial and error testing and resulting in a faster time to market. The Labskin test platform and protocols help clients maintain an optimum real-world environment, when testing their new ingredients and existing products, that shows the positive or negative impact on skin's natural microflora.

 

Environmental Test Services Division, which comprises Modern Water activities:

Modern Water is the environmental division of DeepVerge that has developed and commercialised cutting-edge technology, focused on monitoring of contaminated water and decontamination of wastewater, making recycling of water more efficient. Six countries across the world have legislated that Modern Water monitoring test systems are written into their environmental protection legislation. The division offers an automated real-time contamination detection range of equipment, including Microtox® PD, for the identification of SARS-CoV-2 hotspots and other pathogens in wastewater.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCBKCBQPBKDCOD
Date   Source Headline
27th Dec 20237:00 amRNSCancellation - DEEPVERGE PLC
20th Dec 202312:30 pmRNSUpdate; exclusivity agreement with Microsaic
13th Dec 20234:38 pmRNSUpdate
14th Sep 20237:00 amRNSNew Website, Update
7th Aug 20232:30 pmRNSDisposal;Update; Related Party Trans'n-replacement
7th Aug 20237:00 amRNSDisposal; Update
2nd Aug 20239:35 amRNSBoard Change
1st Aug 20237:00 amRNSCompany Secretary Change
12th Jul 20237:00 amRNSUpdate
5th Jul 202311:26 amRNSUpdate
26th Jun 20237:30 amRNSSuspension - Deepverge PLC
26th Jun 20237:00 amRNSSale or closure of subsidiaries; share suspension
5th Jun 20237:00 amRNSCost reductions;delay to Ann. Report;New contract
19th Apr 20231:21 pmRNSMicrosaic Creditor; Update
17th Apr 20237:00 amRNS2022 revenue update - revision
24th Mar 202310:24 amRNSChange of Auditor
6th Mar 20234:35 pmRNSPrice Monitoring Extension
6th Mar 20232:05 pmRNSSecond Price Monitoring Extn
6th Mar 20232:00 pmRNSPrice Monitoring Extension
22nd Feb 20234:40 pmRNSSecond Price Monitoring Extn
22nd Feb 20234:35 pmRNSPrice Monitoring Extension
7th Feb 20237:00 amRNSBoard Appointment
6th Feb 20235:30 pmRNSSignificant contract win and Board change
2nd Feb 20234:40 pmRNSSecond Price Monitoring Extn
2nd Feb 20234:35 pmRNSPrice Monitoring Extension
9th Jan 20237:00 amRNS2022 Revenue Update
23rd Nov 20224:10 pmRNSTR-1: Notification of major holdings
22nd Nov 20227:00 amRNSAccelerated Restructuring
16th Nov 20229:00 amRNSDirector/PDMR Shareholding
14th Nov 202212:16 pmRNSResult of Meeting
11th Nov 20224:37 pmRNSHolding(s) in Company
7th Nov 20227:00 amRNSDirectorate and Management Changes
3rd Nov 202212:32 pmRNSDirectorate Change
1st Nov 20223:56 pmRNSResult of Broker Offer; Total Voting Rights
31st Oct 20222:23 pmRNSBroker Offer to raise a max of £2.5m - replacement
31st Oct 20222:18 pmRNSExtension of Broker Offer to 430pm on 31 October
28th Oct 20221:06 pmRNSExtension of Broker Offer
27th Oct 20227:01 amRNSBroker Offer to raise a maximum of £2.5m
27th Oct 20227:00 amRNS£10m Placing, Broker Option, RPTs, Notice of GM
25th Oct 20222:05 pmRNSSecond Price Monitoring Extn
25th Oct 20222:00 pmRNSPrice Monitoring Extension
25th Oct 20227:01 amRNSUpdate - Proposed Financing,Proposed Board Changes
25th Oct 20227:00 amRNSHistorical Related Party Transactions
12th Oct 20224:41 pmRNSSecond Price Monitoring Extn
12th Oct 20224:35 pmRNSPrice Monitoring Extension
12th Oct 20227:04 amRNSResponse to Market Speculation
11th Oct 202211:05 amRNSSecond Price Monitoring Extn
11th Oct 202211:00 amRNSPrice Monitoring Extension
4th Oct 20227:00 amRNSLabskin contract
30th Sep 20224:41 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.